Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Iterum Therapeutics plc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 15 | 16 | +1 |
| Shares | 226.9K | 386.6K | +159.8K (+70.4%) |
| Value | $184.0K | $761.6K | +$577.6K (+314.0%) |
New holders (3)
Institutions that held Iterum Therapeutics plc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Apollon Financial, LLC | 200,000 | $394.0K | 0.16% |
| Royal Bank of Canada | 10,000 | $20.0K | 0.00% |
| UBS Group AG | 4,949 | $9.75K | 0.00% |
Sold out (2)
Institutions that held Iterum Therapeutics plc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Citadel Advisors LLC | 19,566 | $16.2K |
| Tower Research Capital LLC (TRC) | 22 | $18 |